Bitter herbs are among Europe's oldest remedies. Gentian, wormwood, dandelion, artichoke, and yarrow are found in almost all epochs of Central European medicinal plant tradition – not as random occurrences, but because their effects on digestion, liver, and bile flow were empirically well-known. What naturopathy has known for centuries, modern science is only now beginning to unravel in its full complexity: bitter plant compounds activate not only taste receptors on the tongue but a far-reaching recognition system that extends throughout the entire digestive tract and regulates the release of several digestive and satiety hormones. Research from 2024 and 2025 provides precise new insights – and rehabilitates a taste that the food industry has systematically bred out over decades.
What are bitter compounds – and why are they missing today?
Bitter compounds are not a homogeneous chemical class but a collective term for structurally diverse secondary plant compounds that all share one thing: their bitter taste. Chemically, they are usually sesquiterpene lactones, iridoid glycosides, alkaloids, or phenolic compounds. In the plant, they primarily serve as defense substances against herbivores and pathogens.
Classic Central European bitter compound plants include:
- Artichoke (Cynara cardunculus var. scolymus) – key substance cynarin
- Dandelion (Taraxacum officinale) – key substances taraxacin, taraxasterol
- Wormwood (Artemisia absinthium) – key substance absinthin
- Common Centaury (Centaurium erythraea) – key substances erythaurin, swertiamarin
- Gentian (Gentiana lutea) – key substance amarogentin
- Yarrow (Achillea millefolium) – key substances achillin, flavonoids
The problem is well-known: modern vegetables have been bred for decades for milder, sweeter taste profiles. Bitter compounds – and with them valuable aroma components – have largely been lost in the process. Humans today consume a fraction of the bitter compound amount that characterized the diet of earlier generations. What this means is shown by current receptor research.
TAS2R: When the tongue is just the beginning
For a long time, it was thought: bitter plants taste unpleasant, stimulate salivation, and that was it. Modern molecular biology paints a fundamentally different picture. Humans have 25 different bitter receptor subtypes, called TAS2R receptors (Taste 2 Receptors), which are evolutionarily detectable as early as the Cambrian period – long before there was a tongue.
These receptors are by no means limited to the oral cavity. They are found throughout the mucosa of the stomach and intestines, in enteroendocrine cells, Paneth cells, goblet cells, and brush border cells. A particularly relevant finding was provided by a review article in Critical Reviews in Food Science and Nutrition (2025): intestinal TAS2R receptors regulate the release of important gut hormones – including GLP-1 (Glucagon-like Peptide 1), CCK (Cholecystokinin), and PYY (Peptide YY) – thereby influencing appetite, satiety, food intake, and energy metabolism. TAS2R expression is genetically influenced, dependent on the gut microbiome, age- and gender-dependent, and changes in obesity in an organ-specific manner.
A study by the University of Piemonte Orientale, published in the International Journal of Molecular Sciences in 2025, for the first time directly investigated the effect of absinthin (the main bitter compound in wormwood) on human intestinal smooth muscle cells via the TAS2R46 receptor. The result: absinthin triggers rapid membrane depolarization and calcium influx, leading to accelerated cell contraction. The researchers conclude that TAS2R38 and TAS2R46 are involved in the regulation of intestinal peristalsis – and recommend these receptors as possible targets for new therapies. This is the first direct evidence of a contractile effect of these TAS2R subtypes on intestinal muscle cells.
Liver and Gallbladder: The Traditional Core Area
The choleretic effect of bitter compound plants – i.e., their ability to stimulate bile production and secretion – is one of the best-documented effects in phytotherapy. The mechanism is direct: bitter substances activate TAS2R receptors upon initial contact with the tongue, which, via a neural reflex (parasympathetic nervous system), triggers the preparation of the digestive tract. Simultaneously, they stimulate receptors in the stomach and duodenum, leading to the release of digestive enzymes and bile acids.
For the artichoke (Cynara cardunculus var. scolymus), a particularly solid data basis exists. The key substance cynarin (1,3-dicaffeoylquinic acid), along with chlorogenic acid and the flavonoid luteolin, is responsible for the choleretic effect. In a placebo-controlled double-blind study with direct intraduodenal application of 1.92 g of standardized artichoke extract, an increase in bile flow rate of 127% after 30 minutes and 151% after 60 minutes was documented. For the hepatoprotective properties, a randomized controlled study on patients with non-alcoholic steatohepatitis (NASH) is available: daily administration of 2,700 mg of artichoke leaf extract over two months led to a significant reduction in liver enzymes ALT and AST, as well as cholesterol and triglyceride levels, compared to placebo.
Dandelion (Taraxacum officinale) is one of Europe's most widely used traditional liver plants – and the subject of a review article published in Pharmaceuticals in 2025 (Herrera Vielma et al., University of Talca) that summarizes five decades of research. The hepatoprotective effect is primarily attributed to the pentacyclic triterpene taraxasterol, which modulates inflammatory and oxidative stress pathways, stabilizes hepatocyte membranes, and increases the liver's glutathione production – the central endogenous antioxidant. The sesquiterpene lactones of the root (including taraxacin) activate the release of digestive juices via TAS2R receptors in the intestinal tract. The European Scientific Cooperative on Phytotherapy (ESCOP) certifies dandelion root as a remedy for supporting liver and bile function, with scientifically proven application for digestive complaints and loss of appetite.
Appetite Regulation: The Natural GLP-1 Effect
An aspect of bitter compound research that is currently being investigated particularly intensively concerns satiety regulation. TAS2R receptors in enteroendocrine cells of the gut, after contact with bitter compounds, trigger the release of GLP-1 and CCK – both hormones that enhance satiety, slow gastric emptying, and reduce food intake.
This mechanism is the same one that synthetic GLP-1 agonists (known under brand names like Ozempic or Wegovy) exploit pharmacologically – albeit with significantly lower intensity and without systemic side effects. A 2021 meta-analysis evaluating several clinical studies on bitter compound interventions before meals concluded that bitter stimuli showed the strongest influence on eating behavior among the interventions studied. The study from ScienceDirect (2024) by Depoortere et al. further demonstrates that bitter compounds, via TAS2R receptors, can induce not only GLP-1 but also the stress factor GDF15, which also acts as a satiety signal in the hindbrain.
Research in this area is not yet complete. The exact dose-dependency in humans and the question of which bitter compound plants trigger the strongest GLP-1 response are actively being investigated.
Bitter Compounds and the Gut Microbiome
Another field of research concerns the interaction of bitter compounds with the intestinal microbiome. TAS2R expression in the gut – as studies show – is directly influenced by the composition of the gut microbiome. Conversely, phenolic bitter compounds influence microbial composition: many bitter compound plants contain inulin or other fructooligosaccharides, which act as selective prebiotics and promote the growth of beneficial bacterial strains. Dandelion and artichoke are particularly rich in inulin; artichoke inulin has been shown to also influence bile salt reabsorption via the enterohepatic circulation and thus indirectly modulate fat metabolism.
Safety and Precautions
Bitter herb compounds in usual dietary amounts or as standardized extracts in recommended dosages are considered very well tolerated. In cases of bile duct obstruction, acute cholecystitis, or severe liver disease, the use of choleretic bitter compound plants is contraindicated – increased bile mobilization may be undesirable in these situations. Individuals with known allergies to composite flowers (Asteraceae) should exercise caution with artichoke, dandelion, and yarrow. For pregnant and breastfeeding women: bitter compound preparations in therapeutic dosages should only be taken after consulting a doctor.
Unlike green tea, no hepatotoxic effects have been reported for bitter compound extracts with moderate use so far. However, very high doses of wormwood preparations (especially essential wormwood oil containing thujone) are neurotoxic and not suitable for prolonged use. Standardized dry extracts in recommended dosages are not affected by this.
When taking medications metabolized by the liver, possible interactions should be considered; medical consultation is recommended.
Quality and Application
The concentration of active ingredients in bitter compound plants varies considerably depending on the harvest time, cultivation region, and processing methods. Artichoke leaves contain significantly higher cynarin concentrations than the artichoke fruit itself. Dandelion root, harvested in autumn, has higher inulin and bitter compound contents than roots harvested in spring.
For optimal active ingredient extraction, for herbal teas and extracts: bitter compound plants should ideally be extracted for 5–10 minutes in non-boiling water (80–90 °C). The bitter fraction is highly water-soluble; alcoholic extracts also capture lipophilic components like some sesquiterpene lactones more completely.
Those aiming for satiety and digestive stimulation should take bitter compound preparations – as was traditionally done – before or at the beginning of a meal. Timing is relevant: TAS2R receptors in the gut respond to bitter compound contact with a measurable hormone release that peaks within 20–30 minutes.
Conclusion
Recent research on bitter compounds paints a remarkable picture: what was once considered a simple taste principle turns out to be a complex chemosensory system extending from the tongue to the gut, influencing digestion, liver-bile function, peristalsis, and satiety hormones. At the same time, bitter compounds have largely disappeared from the modern diet – due to high-yielding varieties, processing methods, and a taste education towards sweetness.
Traditional European bitter compound plants such as artichoke, dandelion, and wormwood are not relics of naturopathy but subjects of active scientific research. The evidence for their effects on bile flow, liver protection, and digestion is solid. However, bitter compound research is not a closed field – dosage questions, individual TAS2R genetics, and long-term effects in humans are still being investigated.
| Area of Application | Effect | Evidence Level |
|---|---|---|
| Bile flow / Digestion | Increase in bile acid production and secretion | Clinically proven (choleretic effect of artichoke) |
| Liver protection | Antioxidant, hepatoprotective (taraxasterol, cynarin) | Clinical studies, Narrative Review 2025 |
| Intestinal peristalsis | TAS2R38/46 activation by absinthin/PTC | In vitro study on human cells (IJMS 2025) |
| Satiety / Appetite | Release of GLP-1, CCK, PYY via TAS2R | Meta-analysis and mechanistic studies |
| Gut microbiome | Prebiotic effect (inulin), TAS2R modulation | Review articles, in vivo models |
| Safety | Well tolerated in standard dosage; contraindication in biliary tract diseases | General scientific consensus |
Sources
Camillo L, Pollastro F, Talmon M, Fresu LG: Bitter Taste Receptors 38 and 46 Regulate Intestinal Peristalsis. Int J Mol Sci. 2025 Feb 27;26(5):2092. doi: 10.3390/ijms26052092 — PubMed Central (Open Access)
Herrera Vielma F et al.: The Role of Dandelion (Taraxacum officinale) in Liver Health and Hepatoprotective Properties. Pharmaceuticals. 2025 Jul 1;18(7):990. doi: 10.3390/ph18070990 — PubMed
Intestinal bitter taste receptors in health: a multifactorially regulated role from the perspective of metabolic crosstalk. Critical Reviews in Food Science and Nutrition. 2025. doi: 10.1080/10408398.2025.2563176 — Taylor & Francis
Sternini C, Rozengurt E: Bitter taste receptors as sensors of gut luminal contents. Nat Rev Gastroenterol Hepatol. 2025 Jan;22(1):39–53. doi: 10.1038/s41575-024-01005-z — PubMed
Depoortere I et al.: Bitter-tasting drugs tune GDF15 and GLP-1 expression via bitter taste or motilin receptors in the intestine of patients with obesity. EBioMedicine. 2024. doi: 10.1016/j.ebiom.2024.105215 — ScienceDirect
Avau B et al.: Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation. Sci Rep. 2015;5:15985. doi: 10.1038/srep15985 — PubMed Central (Open Access)
Klaassen T et al.: Effects of gastrointestinal delivery of non-caloric tastants on energy intake: a systematic review and meta-analysis. Eur J Nutr. 2021;60(6):2923–2947. doi: 10.1007/s00394-021-02485-4 — PubMed Central (Open Access)
Rangboo V et al.: The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. Int J Hepatol. 2016;2016:4030476. doi: 10.1155/2016/4030476 — PubMed Central (Open Access)
Kirchhoff R et al.: Increase in choleresis by means of artichoke extract. Phytomedicine. 1994;1(2):107–115. doi: 10.1016/S0944-7113(11)80027-9 — PubMed
European Scientific Cooperative on Phytotherapy (ESCOP): Taraxaci radix. ESCOP Monographs, 2nd Ed. — escop.com
Dal Cero M et al.: Trends of Medicinal Plant Use over the Last 2000 Years in Central Europe. Plants. 2023;12(1):135. doi: 10.3390/plants12010135 — PubMed Central (Open Access)
